Stock listing
PRTA Stock Price, News, Filings & Events — Prothena Corporation Plc
Selected listing: PRTA · NASDAQ · USD · US
This page tracks Prothena Corporation Plc's PRTA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PRTA:NASDAQ. PRTA:NASDAQ is the stock-level entry point for investors researching Prothena Corporation Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Prothena Corporation Plc is a public company traded under the ticker PRTA in the American market. The company has a market capitalization of approximately $458 million. Prothena focuses on developing transformative therapies for diseases with high unmet medical needs.
- Ticker
- PRTA:NASDAQ
- Asset type
- Stock
- Market cap
- $458.4M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Prothena Corporation Plc PRTA:NASDAQ stock context
This page tracks Prothena Corporation Plc's PRTA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PRTA:NASDAQ. PRTA:NASDAQ is the stock-level entry point for investors researching Prothena Corporation Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Prothena Corporation Plc is a public company traded under the ticker PRTA in the American market. The company has a market capitalization of approximately $458 million. Prothena focuses on developing transformative therapies for diseases with high unmet medical needs.
Latest news from Prothena Corporation Plc
Prothena to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
September 9, 2026
Prothena Reports Second Quarter 2026 Financial Results and Business Highlights
August 6, 2026
Prothena to Report Second Quarter 2026 Financial Results on August 6
July 30, 2026
Prothena Reports First Quarter 2026 Financial Results and Business Highlights
May 7, 2026
Prothena to Report First Quarter 2026 Financial Results on May 7
April 30, 2026
Prothena Corporation Plc earnings calls
Prothena Corporation plc (PRTA) Q4 2025 Earnings Call
February 19, 2026 · Replay with transcript and chapters
Prothena Corporation plc (PRTA) Q4 2024 Earnings Call
February 20, 2025 · Replay with transcript and chapters
Prothena Corporation plc (PRTA) Q4 2023 Earnings Call
February 15, 2024 · Replay with transcript and chapters
Prothena Corporation plc (PRTA) Q4 2022 Earnings Call
February 23, 2023 · Replay with transcript and chapters
Prothena Corporation plc (PRTA) Q4 2021 Earnings Call
February 17, 2022 · Replay with transcript and chapters
Prothena Corporation plc (PRTA) Q4 2020 Earnings Call
February 11, 2021 · Replay with transcript and chapters
Research Prothena Corporation Plc
Prothena Corporation Plc investor report
Review AI stock analysis and investor report context for PRTA:NASDAQ.
Prothena Corporation Plc company profile
View the public company page for Prothena Corporation Plc on 6ix.
Prothena Corporation Plc news
Read company news and market updates connected to Prothena Corporation Plc.
Prothena Corporation Plc investor events
Find investor webinars, events, and replay context for Prothena Corporation Plc.
Alternate listings
0PT:TRADEGATE
DE · EUR
Alternate listing for Prothena Corporation Plc; the primary context on this page is PRTA:NASDAQ.
0PT:GETTEX
DE · EUR
Alternate listing for Prothena Corporation Plc; the primary context on this page is PRTA:NASDAQ.
A1KAVV:LSX
DE · EUR
Alternate listing for Prothena Corporation Plc; the primary context on this page is PRTA:NASDAQ.
A1KAVV:LS
DE · EUR
Alternate listing for Prothena Corporation Plc; the primary context on this page is PRTA:NASDAQ.
0Y3M:LSE
GB · USD
Alternate listing for Prothena Corporation Plc; the primary context on this page is PRTA:NASDAQ.
PRTA:BOATS
US · USD
Alternate listing for Prothena Corporation Plc; the primary context on this page is PRTA:NASDAQ.
0PT:DUS
DE · EUR
Alternate listing for Prothena Corporation Plc; the primary context on this page is PRTA:NASDAQ.
0PT:FWB
DE · EUR
Alternate listing for Prothena Corporation Plc; the primary context on this page is PRTA:NASDAQ.
0PT:MUN
DE · EUR
Alternate listing for Prothena Corporation Plc; the primary context on this page is PRTA:NASDAQ.
0PT:SWB
DE · EUR
Alternate listing for Prothena Corporation Plc; the primary context on this page is PRTA:NASDAQ.